| New Vista Of The Bluegrass Inc | |
|
201 Mechanic St Lexington KY 40507-1086 | |
| (859) 253-1686 | |
| Not Available |
| Full Name | New Vista Of The Bluegrass Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 201 Mechanic St, Lexington, Kentucky |
| Authorized Official Name and Position | Dee Werline (PRESIDENT AND CEO) |
| Authorized Official Contact | 8592531686 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| New Vista Of The Bluegrass Inc 1351 Newtown Pike Lexington KY 40511-1275 Ph: () - | New Vista Of The Bluegrass Inc 201 Mechanic St Lexington KY 40507-1086 Ph: (859) 253-1686 |
| NPI Number | 1023359783 |
|---|---|
| Provider Enumeration Date | 03/06/2013 |
| Last Update Date | 10/12/2020 |
| Certification Date | 10/12/2020 |
| Medicare PECOS PAC ID | 6608773619 |
|---|---|
| Medicare Enrollment ID | O20200401003214 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the high rate of chromosomal abnormalities in patients in whom noninvasive prenatal testing fails to provide results.
Oncotarget published "Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study" which reported that the authors examined the association of high-sensitivity CRP with odds of BC by molecular subtype among Nigerian women.
Fewer than 60% of young women diagnosed with sexually transmitted infections in the emergency department fill prescriptions for antimicrobial therapy to treat these conditions, according to a research letter published online May 28, 2019, by JAMA Pediatrics.
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
Alkermes plc today announced positive topline results from a phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023359783 | NPI | - | NPPES |
| 20354400 | Other | KY | MAGELLAN |
| 270151015 | Medicaid | KY | |
| 874068 | Other | KY | USA |
| 000000057414 | Other | KY | ATHEM |
| 1790731081 | Medicaid | KY | |
| 091018 | Other | KY | VALUE OPTIONS |
| 207023 | Other | KY | MHN |
| 101483 | Other | KY | CHA INSURANCE |
| 28015014 | Medicaid | KY | |
| 29000003 | Medicaid | KY | |
| 33900119 | Medicaid | KY | |
| 242395 | Other | KY | COMPSYCH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the high rate of chromosomal abnormalities in patients in whom noninvasive prenatal testing fails to provide results.
Oncotarget published "Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study" which reported that the authors examined the association of high-sensitivity CRP with odds of BC by molecular subtype among Nigerian women.
Fewer than 60% of young women diagnosed with sexually transmitted infections in the emergency department fill prescriptions for antimicrobial therapy to treat these conditions, according to a research letter published online May 28, 2019, by JAMA Pediatrics.
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
Alkermes plc today announced positive topline results from a phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression.
› Verified 4 days ago
Alexander J. Tikhtman, M.d., P.s.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1517 Nicholasville Rd, Suite 403, Lexington, KY 40503 Phone: 859-276-6168 Fax: 859-276-0850 | |
Verbal Behavior Consulting, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1035 Strader Dr Ste 150, Lexington, KY 40505 Phone: 859-899-9200 Fax: 859-899-9202 | |
Thomas-peeples & Associates, Psc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 106 Dennis Dr, Lexington, KY 40503 Phone: 859-278-4775 Fax: 859-373-0018 | |
Kvc Behavorial Healthcare Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 900 Beasley St, Lexington, KY 40509 Phone: 859-254-1035 | |
Andre N. Fernandez Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 501 Darby Creek Rd, Suite 21, Lexington, KY 40509 Phone: 859-263-9305 Fax: 859-264-1169 | |
Mended Counseling & Trauma Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 824 Euclid Ave Ste A102, Lexington, KY 40502 Phone: 859-338-0006 | |
Wisdom Of The Heart, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 535 W Second St Ste 207, Suite 207, Lexington, KY 40508 Phone: 859-338-8720 Fax: 859-255-5385 |